Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SGRY · against 1,336 other Healthcare companies
Ranked #596 of 1,337 · scores higher than 55% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 50–59, including SGRY · Click a bar to see the companies
A mix: stronger free cash flow yield and EBITDA yield, but weaker earnings yield than most Healthcare peers.
| Metric | SGRY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -3.0% | 1.5% | 31% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 7.5% | 4.2% | 70% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 6.2% | -1.0% | 84% | 20% | |
| Book yieldHigher is better · 1,306 reported | 55.7% | 37.9% | 67% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 596 | 1.13T INR (≈$13.5B) | 55 | 61 | |
| 596 | 494.7B INR (≈$5.9B) | 55 | 70 | |
| 596 | 45.6B CHF (≈$52.4B) | 55 | 55 | |
| 596 | 1.6B USD | 55 | 51 | |
| 596 | 3.0B USD | 55 | 39 | |
| 596 | 48.9B USD | 55 | 54 | |
| 596 | 9.3B USD | 55 | 64 | |
| 596 | 134.5B USD | 55 | 70 | |
| 609 | 3.1B CNY (≈$437M) | 54 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score